BIOGEN INC. Non-operating Income/Expense 2007-2026 | BIIB
Beta
What is BIOGEN INC.'s current non-operating income/expense?
BIOGEN INC. (BIIB) annual non-operating income/expense for 2025 was $-24.7M, a 848.48% decline from 2024. BIOGEN INC. non-operating income/expense for the quarter ending March 31, 2026 was $-1.1M.
What was BIOGEN INC.'s non-operating income/expense in 2024?
BIOGEN INC. annual non-operating income/expense for 2024 was $3.3M, a 925.00% increase from 2023.
What was BIOGEN INC.'s non-operating income/expense in 2023?
BIOGEN INC. annual non-operating income/expense for 2023 was $-400,000, a 103.96% decline from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$497.4M
→
FY2025
$-24.7M
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-24.7M | -848.5% | 10-K |
| FY2024 | $3.3M | +925.0% | 10-K |
| FY2023 | $-400,000 | -104.0% | 10-K |
| FY2022 | $10.1M | +100.9% | 10-K |
| FY2021 | $-1.10B | -320.2% | 10-K |
| FY2020 | $497.4M | +497.1% | 10-K |
| FY2019 | $83.3M | +657.3% | 10-K |
| FY2018 | $11.0M | +105.1% | 10-K |
| FY2017 | $-217.0M | +0.8% | 10-K |
| FY2016 | $-218.7M | -76.8% | 10-K |
| FY2015 | $-123.7M | -379.5% | 10-K |
| FY2014 | $-25.8M | +26.1% | 10-K |
| FY2013 | $-34.9M | -4590.9% | 10-K |
| FY2012 | $-744,000 | +94.5% | 10-K |
| FY2011 | $-13.5M | +29.0% | 10-K |
| FY2010 | $-19.0M | -151.0% | 10-K |
| FY2009 | $37.3M | +164.5% | 10-K |
| FY2008 | $-57.7M | -179.7% | 10-K |
| FY2007 | $72.4M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →